Kazuko Masuo

Associate Professor Kazuko Masuo, MD., PhD. is currently working as an Associate Medical Director in the Nucleus Network Ltd., Baker IDI Heart & Diabetes Institute, and an Academic Fellow in the Baker IDI Heart & Diabetes Institute, in Melbourne, Victoria, Australia. She graduated as MD and received PhD at the Department of Geriatric Medicine and the Department of Pharmacology in Osaka University Postgraduate School of Medicine, Osaka, Japan, under supervision of Professors Kumahara and Ogihara. She conducted a series of longitudinal studies over 10 years investigating weight change and neurohormonal changes, and these studies were a mile stone research to understand how obesity impacts on hypertension, diabetes, and cardiac- and renal-complications, and how to manage these conditions. She is a certificated specialist in cardiology, endocrinology, nephrology and gerontology, and in several editorial boards for medical journals. She has >100 publications in international, peer reviewed medical journals on obesity, hypertension, diabetes, genetics and renal dysfunction, 15 book chapters, and has edited 6 books.

1books edited

4chapters authored

Latest work with IntechOpen by Kazuko Masuo

Type 2 diabetes is now a global serious health problem. Patients with type 2 diabetes have 2-4 times higher risk of cardiovascular and renal complications, morbidity and mortality. This book, Type 2 Diabetes, is a unique book covering the topics including pathophysiology, complications and prevention and treatments. Understanding the etiology of the onset and development of type 2 diabetes is important to prevent type 2 diabetes complications and delay the progress. The Pathophysiology section covers a wide range of mechanisms and characteristics from the micro (molecular) to the macro (neurohormonal mechanisms and the beta-cell function in the pancreas). The Complications section includes renal complications, sympathetic nervous system imbalance, atherosclerosis, and foot ulcers which are frequently observed in diabetic patients. Finally, the Prevention and Treatments section consists of non-pharmacological treatments, bariatric surgery, pharmacological therapy, and insulin therapy. The editor hopes that this book is helpful for your clinical practice and research, and this book facilitates the reduction of global burden of type 2 diabetes.

Go to the book